Outi Lapatto-Reiniluoto

6PUBLICATIONS
10CO-AUTHORS
Biologically active moleculesPharmacogenomicsDisease surveillanceCancer therapy (excl. chemotherapy and radiation therapy)Human impacts of climate change and human adaptation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 14, 2025
Repeated Intake of Grapefruit Juice Inhibits CYP2B6, CYP2C9, CYP2C19, and CYP3A4 while Lingonberry Powder Does Not Induce Major CYP Enzymes in Humans.

Laura Aurinsalo, Outi Lapatto-Reiniluoto, Mika Kurkela

|Feb 21, 2025
A Phenotyping Tool for Seven Cytochrome P450 Enzymes and Two Transporters: Application to Examine the Effects of Clopidogrel and Gemfibrozil.

Laura Aurinsalo, Outi Lapatto-Reiniluoto, Mika Kurkela

|Oct 12, 2023
Drug-related deaths in a university hospital: Comparison to previous decades.

Mirjam Kauppila, Janne T Backman, Mikko Niemi

|Oct 03, 2023
Ticagrelor Increases Exposure to the Breast Cancer Resistance Protein Substrate Rosuvastatin.

Minna Lehtisalo, E Katriina Tarkiainen, Mikko Neuvonen

|May 23, 2022
Medicines, environment and clinical pharmacology.

Outi Lapatto-Reiniluoto, Mia Siven, Janne T Backman

|Nov 14, 2020
Incidence, preventability, and causality of adverse drug reactions at a university hospital emergency department.

Mirjam Kauppila, Janne T Backman, Mikko Niemi

Pageof 1